FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker independent. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.
QBE Insurance expects reduced profitability in 2019 as a result of frost damage impacting on the North American crop in the second half.
The Chartist continues to believe in overall buyer interest in gold, but there remains a risk of a break-down.
Independent Investment Research updates developments in Australias listed investment trust and provides comparative data.
Brokers anticipate the acquisition of Church Community Builder by Pushpay Holdings will provide additional value and stabilise front book growth.
Peter Switzer of the Switzer Report outlines his expectations for the world and Australia in the next year.
Vehicle leasing and salary packaging business Smartgroup has succumbed to earnings pressure as its add-on insurance underwriter makes changes to product terms.
Sigma Healthcare has adjusted guidance to account for the renewed Chemist Warehouse contract, while Australian Pharmaceutical Industries finally takes its hat out of the merger ring.
Michael Gable of Fairmont Equities believes BHP Group is set to push through its prior high early next year.
Weebit Nano is making progress in China and South Korea
Property manager Charter Hall and its convoy of investment vehicles have alighted at some significant property, including the Huntingwood site of the famous Arnotts Biscuits in Sydney.
Andrew Page of makes the case for index fund investment.
A glance through the latest expert views and predictions about commodities. Resources in 2020; coal; base metals; gold; iron ore; and lithium.
Creso Pharma has begun launch preparations of the cannaQIX range into Africa. Integrating into the African market is part of Cresos drive to deliver its flagship medicinal cannabis product cannaQIX 50 into new markets.
BPH Energy Limited investee Patagonia Genetics has acquired the rights to a recently discovered and rare high CBD hemp strain.
Consensus price targets can be a useful tool to assess whether stocks are running too hard, or falling too deeply.
Relative ranking of ASX200 stocks in accordance with consensus forecasts for growth, valuation and yield.
Evaluate circa 400 ASX-listed stocks on the basis of High/Low expert sentiment, forecast dividend yield.